Private Capital Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $8K | Sell |
263
-18
| -6% | -$548 | 0.01% | 1125 |
|
|
2022
Q1 | $9K | Buy |
281
+53
| +23% | +$1.7K | ﹤0.01% | 1318 |
|
|
2021
Q4 | $7K | Buy |
228
+6
| +3% | +$184 | ﹤0.01% | 1448 |
|
|
2021
Q3 | $6K | Sell |
222
-48
| -18% | -$1.3K | ﹤0.01% | 1529 |
|
|
2021
Q2 | $8K | Sell |
270
-47
| -15% | -$1.39K | ﹤0.01% | 1424 |
|
|
2021
Q1 | $8K | Buy |
317
+145
| +84% | +$3.66K | ﹤0.01% | 1375 |
|
|
2020
Q4 | $4K | Sell |
172
-73
| -30% | -$1.7K | ﹤0.01% | 1623 |
|
|
2020
Q3 | $5K | Buy |
245
+62
| +34% | +$1.27K | ﹤0.01% | 1521 |
|
|
2020
Q2 | $4K | Sell |
183
-61
| -25% | -$1.33K | ﹤0.01% | 1572 |
|
|
2020
Q1 | $4K | Sell |
244
-118
| -33% | -$1.93K | ﹤0.01% | 1557 |
|
|
2019
Q4 | $8K | Buy |
362
+11
| +3% | +$243 | ﹤0.01% | 1406 |
|
|
2019
Q3 | $10K | Sell |
351
-1,028
| -75% | -$29.3K | ﹤0.01% | 1478 |
|
|
2019
Q2 | $83K | Buy |
1,379
+716
| +108% | +$43.1K | 0.02% | 464 |
|
|
2019
Q1 | $23K | Sell |
663
-215
| -24% | -$7.46K | ﹤0.01% | 1128 |
|
|
2018
Q4 | $29K | Sell |
878
-170
| -16% | -$5.62K | 0.01% | 927 |
|
|
2018
Q3 | $52K | Sell |
1,048
-331
| -24% | -$16.4K | 0.01% | 700 |
|
|
2018
Q2 | $82K | Buy |
1,379
+215
| +18% | +$12.8K | 0.02% | 495 |
|
|
2018
Q1 | $53K | Buy |
1,164
+36
| +3% | +$1.64K | 0.01% | 649 |
|
|
2017
Q4 | $45 | Buy |
+1,128
| New | +$45 | 0.01% | 739 |
|